ArticleThe oncologist2022

Update to "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors".

Mojun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.